Modulation of the Innate Immune Response through the Vagus Nerve

Nephron

Volumn 131, Issue 2, 2015, Pages 79-84

  Kox, Matthijs ^a   Pickkers, Peter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cholinergic anti inflammatory pathway; Cytokines; Heart rate variability; Inflammation; Innate immune system; Lipopolysaccharide; Vagus nerve

Indexed keywords

ANIMAL; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; PHYSIOLOGY; VAGUS NERVE;

ANIMALS; HUMANS; IMMUNITY, INNATE; VAGUS NERVE;

EID: 84971551927     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000435843     Document Type: Review

References (60)

1. Laffey JG, Boylan JF, Cheng DC: The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002; 97: 215-252.
2. Maier SF, Goehler LE, Fleshner M, Watkins LR: The role of the vagus nerve in cytokineto-brain communication. Ann N Y Acad Sci 1998; 840: 289-300.
3. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES: The sympathetic nerve-an integrative interface between two supersystems: The brain and the immune system. Pharmacol Rev 2000; 52: 595-638.
4. Gaykema RP, Dijkstra I, Tilders FJ: Subdiaphragmatic vagotomy suppresses endotoxininduced activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion. Endocrinology 1995; 136: 4717-4720.
5. Fleshner M, Goehler LE, Schwartz BA, McGorry M, Martin D, Maier SF, Watkins LR: Thermogenic and corticosterone responses to intravenous cytokines (IL-1beta and TNF-alpha) are attenuated by subdiaphragmatic vagotomy. J Neuroimmunol 1998; 86: 134-141.
6. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-462.
7. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-388.
8. Tracey KJ: The inflammatory reflex. Nature 2002; 420: 853-859.
9. Travagli RA, Hermann GE, Browning KN, Rogers RC: Musings on the wanderer: what's new in our understanding of vago-vagal reflexes III. Activity-dependent plasticity in vago-vagal reflexes controlling the stomach. Am J Physiol Gastrointest Liver Physiol 2003; 284:G180-G187.
10. Niijima A, Hori T, Aou S, Oomura Y: The effects of interleukin-1 beta on the activity of adrenal, splenic and renal sympathetic nerves in the rat. J Auton Nerv Syst 1991; 36: 183-192.
11. Belvisi MG: Overview of the innervation of the lung. Curr Opin Pharmacol 2002; 2: 211-215.
12. Chang HY, Mashimo H, Goyal RK: Musings on the wanderer: what's new in our understanding of vago-vagal reflex IV. Current concepts of vagal efferent projections to the gut. Am J Physiol Gastrointest Liver Physiol 2003; 284:G357-G366.
13. Pavlov VA, Tracey KJ: The cholinergic antiinflammatory pathway. Brain Behav Immun 2005; 19: 493-499.
14. Bellinger DL, Lorton D, Hamill RW, Felten SY, Felten DL: Acetylcholinesterase staining and choline acetyltransferase activity in the young adult rat spleen: lack of evidence for cholinergic innervation. Brain Behav Immun 1993; 7: 191-204.
15. Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, Pavlov VA, Gallowitsch-Puerta M, Ashok M, Czura CJ, Foxwell B, Tracey KJ, Ulloa L: Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 2006; 203: 1623-1628.
16. Rosas-Ballina M, Ochani M, Parrish WR, Ochani K, Harris YT, Huston JM, Chavan S, Tracey KJ: Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci U S A 2008; 105: 11008-11013.
17. Vida G, Pena G, Deitch EA, Ulloa L: 7-cholinergic receptor mediates vagal induction of splenic norepinephrine. J Immunol 2011; 186: 4340-4346.
18. Rosas-Ballina M, Olofsson PS, Ochani M, Valdes-Ferrer SI, Levine YA, Reardon C, Tusche MW, Pavlov VA, Andersson U, Chavan S, Mak TW, Tracey KJ: Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 2011; 334: 98-101.
19. Matteoli G, Gomez-Pinilla PJ, Nemethova A, Di Giovangiulio M, Cailotto C, van Bree SH, Michel K, Tracey KJ, Schemann M, Boesmans W, Vanden Berghe P, Boeckxstaens GE: A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen. Gut 2014; 63: 938-948.
20. van Westerloo DJ, Giebelen IA, Meijers JC, Daalhuisen J, de Vos AF, Levi M, van der Poll T: Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats. J Thromb Haemost 2006; 4: 1997-2002.
21. Huston JM, Gallowitsch-Puerta M, Ochani M, Ochani K, Yuan R, Rosas-Ballina M, Ashok M, Goldstein RS, Chavan S, Pavlov VA, Metz CN, Yang H, Czura CJ, Wang H, Tracey KJ: Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 2007; 35: 2762-2768.
22. Song XM, Li JG, Wang YL, Hu ZF, Zhou Q, Du ZH, Jia BH: The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats. Shock 2008; 30: 468-472.
23. Hofer S, Eisenbach C, Lukic IK, Schneider L, Bode K, Brueckmann M, Mautner S, Wente MN, Encke J, Werner J, Dalpke AH, Stremmel W, Nawroth PP, Martin E, Krammer PH, Bierhaus A, Weigand MA: Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med 2008; 36: 404-408.
24. Levy G, Fishman JE, Xu D, Chandler BT, Feketova E, Dong W, Qin Y, Alli V, Ulloa L, Deitch EA: Parasympathetic stimulation via the vagus nerve prevents systemic organ dysfunction by abrogating gut injury and lymph toxicity in trauma and hemorrhagic shock. Shock 2013; 39: 39-44.
25. Bernik TR, Friedman SG, Ochani M, DiRaimo R, Susarla S, Czura CJ, Tracey KJ: Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 2002; 36: 1231-1236.
26. Yeboah MM, Xue X, Duan B, Ochani M, Tracey KJ, Susin M, Metz CN: Cholinergic agonists attenuate renal ischemia-reperfusion injury in rats. Kidney Int 2008; 74: 62-69.
27. Guarini S, Altavilla D, Cainazzo MM, Giuliani D, Bigiani A, Marini H, Squadrito G, Minutoli L, Bertolini A, Marini R, Adamo EB, Venuti FS, Squadrito F: Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation 2003; 107: 1189-1194.
28. Levine YA, Koopman FA, Faltys M, Caravaca A, Bendele A, Zitnik R, Vervoordeldonk MJ, Tak PP: Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis. PLoS One 2014; 9:e104530.
29. van Maanen MA, Papke RL, Koopman FA, Koepke J, Bevaart L, Clark R, Lamppu D, Elbaum D, LaRosa GJ, Tak PP, Vervoordeldonk MJ: Two novel 7 nicotinic acetylcholine receptor ligands: in vitro properties and their efficacy in collagen-induced arthritis in mice. PLoS One 2015; 10:e0116227.
30. van Maanen MA, Lebre MC, van der Poll T, Larosa GJ, Elbaum D, Vervoordeldonk MJ, Tak PP: Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum 2009; 60: 114-122.
31. Morris GL 3rd, Mueller WM: Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology 1999; 53: 1731-1735.
32. Cristancho P, Cristancho MA, Baltuch GH, Thase ME, O'Reardon JP: Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year. J Clin Psychiatry 2011; 72: 1376-1382.
33. Barone L, Colicchio G, Policicchio D, Di Clemente F, Di Monaco A, Meglio M, Lanza GA, Crea F: Effect of vagal nerve stimulation on systemic inflammation and cardiac autonomic function in patients with refractory epilepsy. Neuroimmunomodulation 2007; 14: 331-336.
34. Majoie HJ, Rijkers K, Berfelo MW, Hulsman JA, Myint A, Schwarz M, Vles JS: Vagus nerve stimulation in refractory epilepsy: effects on pro-and anti-inflammatory cytokines in peripheral blood. Neuroimmunomodulation 2011; 18: 52-56.
35. Corcoran C, Connor TJ, O'Keane V, Garland MR: The effects of vagus nerve stimulation on pro-and anti-inflammatory cytokines in humans: A preliminary report. Neuroimmunomodulation 2005; 12: 307-309.
36. De Herdt V, Bogaert S, Bracke KR, Raedt R, De Vos M, Vonck K, Boon P: Effects of vagus nerve stimulation on pro-and anti-inflammatory cytokine induction in patients with refractory epilepsy. J Neuroimmunol 2009; 214: 104-108.
37. Rossi P, Ricci A, De Paulis R, Papi E, Pavaci H, Porcelli D, Monari G, Maselli D, Bellisario A, Turani F, Nardella S, Azzolini P, Piccirillo G, Quaglione R, Valsecchi S, Bianchi S: Epicardial ganglionated plexus stimulation decreases postoperative inflammatory response in humans. Heart Rhythm 2012; 9: 943-950.
38. Wittebole X, Hahm S, Coyle SM, Kumar A, Calvano SE, Lowry SF: Nicotine exposure alters in vivo human responses to endotoxin. Clin Exp Immunol 2007; 147: 28-34.
39. Kox M, van Velzen JF, Pompe JC, Hoedemaekers CW, van der Hoeven JG, Pickkers P: GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation. Biochem Pharmacol 2009; 78: 863-872.
40. Kox M, Pompe JC, Gordinou de Gouberville MC, van der Hoeven JG, Hoedemaekers CW, Pickkers P: Effects of the 7 nicotinic acetylcholine receptor agonist GTS-21 on the innate immune response in humans. Shock 2011; 36: 5-11.
41. Kosek E, Altawil R, Kadetoff D, Finn A, Westman M, Le Maitre E, Andersson M, Jensen-Urstad M, Lampa J: Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain-interleukin-8 in fibromyalgia and interleukin-1 in rheumatoid arthritis. J Neuroimmunol 2015; 280: 49-55.
42. Kox M, Vrouwenvelder MQ, Pompe JC, van der Hoeven JG, Pickkers P, Hoedemaekers CW: The effects of brain injury on heart rate variability and the innate immune response in critically ill patients. J Neurotrauma 2012; 29: 747-755.
43. Cooper TM, McKinley PS, Seeman TE, Choo TH, Lee S, Sloan RP: Heart rate variability predicts levels of inflammatory markers: evidence for the vagal anti-inflammatory pathway. Brain Behav Immun 2014;pii:S0889-S1591.
44. Sloan RP, McCreath H, Tracey KJ, Sidney S, Liu K, Seeman T: RR interval variability is inversely related to inflammatory markers: The CARDIA study. Mol Med 2007; 13: 178-184.
45. Marsland AL, Gianaros PJ, Prather AA, Jennings JR, Neumann SA, Manuck SB: Stimulated production of proinflammatory cytokines covaries inversely with heart rate variability. Psychosom Med 2007; 69: 709-716.
46. Nikolic VN, Jevtovic-Stoimenov T, Stokanovic D, Milovanovic M, Velickovic-Radovanovic R, Pesic S, Stoiljkovic M, Pesic G, Ilic S, Deljanin-Ilic M, Marinkovic D, Stefanovic N, Jankovic SM: An inverse correlation between TNF alpha serum levels and heart rate variability in patients with heart failure. J Cardiol 2013; 62: 37-43.
47. von Kanel R, Carney RM, Zhao S, Whooley MA: Heart rate variability and biomarkers of systemic inflammation in patients with stable coronary heart disease: findings from the Heart and Soul study. Clin Res Cardiol 2011; 100: 241-247.
48. Kox M, Ramakers BP, Pompe JC, van der Hoeven JG, Hoedemaekers CW, Pickkers P: Interplay between the acute inflammatory response and heart rate variability in healthy human volunteers. Shock 2011; 36: 115-120.
49. Rogausch H, del Rey A, Kabiersch A, Reschke W, Ortel J, Besedovsky H: Endotoxin impedes vasoconstriction in the spleen: role of endogenous interleukin-1 and sympathetic innervation. Am J Physiol 1997; 272:R2048-R2054.
50. Haberthur C, Lehmann F, Ritz R: Assessment of depth of midazolam sedation using objective parameters. Intensive Care Med 1996; 22: 1385-1390.
51. Malik M, Camm AJ: Components of heart rate variability-what they really mean and what we really measure. Am J Cardiol 1993; 72: 821-822.
52. Stavrakis S, Humphrey MB, Scherlag BJ, Hu Y, Jackman WM, Nakagawa H, Lockwood D, Lazzara R, Po SS: Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation. J Am Coll Cardiol 2015; 65: 867-875.
53. de Haan JJ, Windsant IV, Lubbers T, Hanssen SJ, Hadfoune M, Prinzen FW, Greve JW, Buurman WA: Prevention of hemolysis-induced organ damage by nutritional activation of the vagal anti-inflammatory reflex. Crit Care Med 2013; 41:e361-e367.
54. Luyer MD, Greve JW, Hadfoune M, Jacobs JA, Dejong CH, Buurman WA: Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med 2005; 202: 1023-1029.
55. Lubbers T, Kox M, de Haan JJ, Greve JW, Pompe JC, Ramakers BP, Pickkers P, Buurman WA: Continuous administration of enteral lipid-and protein-rich nutrition limits inflammation in a human endotoxemia model. Crit Care Med 2013; 41: 1258-1265.
56. Lieberman JA, Dunbar G, Segreti AC, Girgis RR, Seoane F, Beaver JS, Duan N, Hosford DA: A randomized exploratory trial of an-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia. Neuropsychopharmacology 2013; 38: 968-975.
57. The FO, Boeckxstaens GE, Snoek SA, Cash JL, Bennink R, Larosa GJ, van den Wijngaard RM, Greaves DR, de Jonge WJ: Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice. Gastroenterology 2007; 133: 1219-1228.
58. Saeed RW, Varma S, Peng-Nemeroff T, Sherry B, Balakhaneh D, Huston J, Tracey KJ, Al-Abed Y, Metz CN: Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 2005; 201: 1113-1123.
59. Bregeon F, Xeridat F, Andreotti N, Lepidi H, Delpierre S, Roch A, Ravailhe S, Jammes Y, Steinberg JG: Activation of nicotinic cholinergic receptors prevents ventilator-induced lung injury in rats. PLoS One 2011; 6:e22386.
60. Cedillo JL, Arnalich F, Martin-Sanchez C, Quesada A, Rios JJ, Maldifassi MC, Atienza G, Renart J, Fernandez-Capitan C, Garcia-Rio F, Lopez-Collazo E, Montiel C: Usefulness of 7 nicotinic receptor messenger RNA levels in peripheral blood mononuclear cells as a marker for cholinergic antiinflammatory pathway activity in septic patients: results of a pilot study. J Infect Dis 2015; 211: 146-155.